SBIR/STTR Research Award

Nanofabricated Particles for Biolistic Delivery

Award identifier 8048118c3636017e107b73ab6fc6eb24b023d0f959439a2478d92138b94cd594Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$816,142

Program and phase

SBIR · Phase II

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Seashell Technology LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
KE43JSADEK26
Solicitation number
PHS2006-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The goal of this research project is the continued development of a family of novel nanofabricated particles for use as carriers to deliver a variety of different types of bioactive molecules (DNA, RNA, proteins, peptides) and nanoparticle sensors via particle acceleration methods. The particles are fabricated using the controlled assembly of nanoparticles, polymers and biomolecules via a layer-by-layer technique where the core and subsequent layer each add specific functionality to the final particle. These nanocomposite particles will increase the efficiency and reliability of the currently used biolistic process, and enable novel biolistic delivery applications. These include the delivery of RNAi, antisense oligonucleotides, peptides, and sensors to living cells and tissues for a variety of life science research applications, and for human therapeutic interventions. The key technical objectives to be achieved include the development of manufacturing and process development steps for the production of nanofabricated particles, the documented demonstration of the enhanced efficacy of these particles in a variety of model system applications, and synthesis and characterization of a family of chemically distinct particles with specific functionality. The ability to deliver nucleic acids and polypeptides to cells and tissues of interest is one of the fundamental and required technical achievements that has, in part, been at the foundation of molecular biology, gene therapy and related fields. Particle acceleration methods, also referred to as biolistic delivery, is one of several delivery methods in routine use. Improvements to any of these delivery methods is of relevance to human health because the delivery of nucleic acids, such as DNA, is frequently an essential step in the research and development of medical diseases. The nanofabricated carrier particles we will develop will significantly improve the efficacy of the biolistic delivery process and enable its use in novel applications where currently there is an unmet need.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

36 SBIR/STTR records share this UEI (1997–2015). Reported award amounts total $9,677,389. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.